Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-13

Clinical Trial Update: Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECT [Phase 4]

View source ↗

Summary

Phase 4 study investigating the mechanism of action of depot naltrexone in heroin-dependent patients using functional MRI and SPECT imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone extended-release (Depot) (Naltrexone)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Opioid-Related Disorders, Heroin Dependence | Phase 4 | Status: COMPLETED